Lucy Scientific Discovery, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA54960E1043
USD
0.00
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

1

Shareholding (Dec 2023)

FII

8.44%

Held by 13 FIIs

DII

91.56%

Held by 0 DIIs

Promoter

0.00%

How big is Lucy Scientific Discovery, Inc.?

22-Jun-2025

As of Jun 18, Lucy Scientific Discovery, Inc. has a market capitalization of 0.00, categorizing it as a Micro Cap company, with net sales of 0.02 million and a net profit of -9.99 million over the last four quarters. As of Jun 23, shareholder's funds are 4.68 million and total assets are 8.78 million.

As of Jun 18, Lucy Scientific Discovery, Inc. has a market capitalization of 0.00, which categorizes it as a Micro Cap company.<BR><BR>As of Jun 18, the sum of Net Sales for the latest four quarters is 0.02 Million, while the sum of Net Profit for the same period is -9.99 Million.<BR><BR>As of Jun 23, the reporting period shows Shareholder's Funds at 4.68 Million and Total Assets at 8.78 Million.

Read More

Is Lucy Scientific Discovery, Inc. technically bullish or bearish?

20-Sep-2025

As of September 3, 2025, Lucy Scientific Discovery, Inc. is in a mildly bearish trend with a 100% loss over the past week, month, and year, contrasting with the S&P 500's gains of 1.05%, 2.33%, and 17.14% respectively.

As of 3 September 2025, the technical trend for Lucy Scientific Discovery, Inc. has changed from sideways to mildly bearish. The weekly MACD indicates a mildly bullish stance, but the daily moving averages and weekly Bollinger Bands are both mildly bearish. The monthly RSI shows bullish momentum, yet the KST is bearish on a weekly basis. Overall, the stock is currently in a mildly bearish position with no clear trend from Dow Theory. <BR><BR>The company has experienced a significant decline, with a 100% loss over the past week, month, and year, while the S&P 500 has gained 1.05%, 2.33%, and 17.14% respectively during those periods.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 0 Million ()

stock-summary
P/E

0

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.43

stock-summary
Return on Equity

-773.14%

stock-summary
Price to Book

0.00

Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Dec 2023)
Net Profit:
-1 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
50.0%
0%
50.0%
6 Months
50.0%
0%
50.0%
1 Year
-40.0%
0%
-40.0%
2 Years
-99.99%
0%
-99.99%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Lucy Scientific Discovery, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-87.50%
EBIT Growth (5y)
-171.55%
EBIT to Interest (avg)
-0.30
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.43
Sales to Capital Employed (avg)
0.00
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
9.86%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
0.00
EV to EBIT
-0.08
EV to EBITDA
-0.08
EV to Capital Employed
0.43
EV to Sales
0.43
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-576.53%
ROE (Latest)
-773.14%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
Bullish
Bullish
Bollinger Bands
Mildly Bearish
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2023stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 13 Foreign Institutions (8.44%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'23 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2023 is 0.00% vs 0.00% in Dec 2022",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2023 is -44.44% vs 40.00% in Dec 2022",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.80",
          "val2": "-0.40",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.50",
          "chgp": "-80.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.30",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.30",
          "val2": "-0.90",
          "chgp": "-44.44%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-89,065.40%",
          "val2": "0.00%",
          "chgp": "-8,906.54%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Jun'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Jun 2023 is 0.00% vs 0.00% in Jun 2022",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Jun 2023 is -52.54% vs -25.53% in Jun 2022",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'23",
        "Jun'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-5.70",
          "val2": "-3.50",
          "chgp": "-62.86%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.00",
          "val2": "2.10",
          "chgp": "-4.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.30",
          "val2": "-0.30",
          "chgp": "-333.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-9.00",
          "val2": "-5.90",
          "chgp": "-52.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-818,009.80%",
          "val2": "0.00%",
          "chgp": "-81,800.98%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'23 - YoYstock-summary
Dec'23
Dec'22
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-0.80
-0.40
-100.00%
Interest
0.10
0.50
-80.00%
Exceptional Items
-0.30
0.00
Consolidate Net Profit
-1.30
-0.90
-44.44%
Operating Profit Margin (Excl OI)
-89,065.40%
0.00%
-8,906.54%
USD in Million.
Net Sales

YoY Growth in quarter ended Dec 2023 is 0.00% vs 0.00% in Dec 2022

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2023 is -44.44% vs 40.00% in Dec 2022

Annual Results Snapshot (Consolidated) - Jun'23stock-summary
Jun'23
Jun'22
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-5.70
-3.50
-62.86%
Interest
2.00
2.10
-4.76%
Exceptional Items
-1.30
-0.30
-333.33%
Consolidate Net Profit
-9.00
-5.90
-52.54%
Operating Profit Margin (Excl OI)
-818,009.80%
0.00%
-81,800.98%
USD in Million.
Net Sales

YoY Growth in year ended Jun 2023 is 0.00% vs 0.00% in Jun 2022

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Jun 2023 is -52.54% vs -25.53% in Jun 2022

stock-summaryCompany CV
About Lucy Scientific Discovery, Inc. stock-summary
stock-summary
Lucy Scientific Discovery, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available